The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Neuroendocrine prostate cancer (NEPC) after androgen deprivation therapy (ADT): Clinical characteristics.
Naveed Hassan Akhtar
No relevant relationships to disclose
Himisha Beltran
No relevant relationships to disclose
Muhammad Zubair Afzal
No relevant relationships to disclose
Caryn Ecker
No relevant relationships to disclose
David M. Nanus
No relevant relationships to disclose
Scott T. Tagawa
No relevant relationships to disclose